Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Current Report No. 37/2022

Date of preparation: 28 September 2022

Subject: Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

The Management Board of Captor Therapeutics S.A., based in Wrocław (the "Company"), announces that on 28 September 2022. The Company's Management Board adopted a resolution on the issue of 41,019 series M ordinary bearer shares, within the limits of the Company's authorised capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.

The share issue is related to the implementation of a share-based incentive programme for employees and members of the Company's bodies. Enclosed the Company communicates the content of the adopted resolution.